A difficult-to-treat pleuropulmonary histoplasmosis in a patient with rheumatoid arthritis in Taiwan

Amphotericin B and itraconazole are the primary agents for treating histoplasmosis. Newer azoles are alternatives for patients refractory to or intolerant of standard therapy. We report an 83-year-old woman with rheumatoid arthritis complicated with pleuropulmonary histoplasmosis who responded to li...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Wen-Kai Chu, Un-In Wu, Tai-Fen Lee, Aristine Cheng, Kai-Hsiang Chen, Kuan-Yin Lin, Yee-Chun Chen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2023-02-01
coleção:	Journal of Microbiology, Immunology and Infection
Assuntos:	Histoplasma capsulatum Rheumatoid arthritis Salvage treatment Voriconazole Posaconazole Non-endemic area
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S1684118222002869
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!